Showing results (451-460 of 733) with videos related to

Sort By:
Pageof 74
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Cancer Cell|August 16, 2011
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stromaVictoria Sanz-Moreno, Cedric Gaggioli, Maggie Yeo, et al.
JCO Precision Oncology|February 9, 2022
Elevated Levels of BRAF Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic MelanomaWilliam Lu, Luciana Burton, James Larkin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V Long, Hao Tang, Keyur Desai, et al.
Clinical Kidney Journal|October 1, 2025
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysisBrett Duane, James Larkin, Marialuisa Caiazzo, et al.
International Urology and Nephrology|February 3, 2026
Comparing environmental footprints of haemodialysis and online haemodiafiltration in ItalyJames Larkin, Giulia Ligabue, Niccolo Morisi, et al.
Nature Cancer|May 31, 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancerYin Wu, Dhruva Biswas, Ieva Usaite, et al.
British Journal of Cancer|January 4, 2023
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Molecular Oncology|May 28, 2025
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumabCharles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Pageof 74